top of page

Low Cost, Highly Accurate, Simple to Use
Testing for All

Domus Diagnostics is working to combine cutting-edge custom chemistry with simple manufacturing technology in order to bring low-cost, high accuracy tests for infectious diseases everywhere they're needed.

Domus technology has disruptive potential across the continuum of care.

Proprietary* RT-LAMP one-step, one-temperature technology allows for high performance, low-cost solutions everywhere you find diagnostic tests


At Home

Disposable, no-electricity home-resulting test


Low-cost, no-service Desktop instrument

central lab-3.png

Central Laboratories

Lab-developed one-step tests; dedicated assays for established analyzer platforms

Domus tests will be among the first to meet the standards required for broad adoption in every global market.


Low Cost

Novel chemistry and simple manufacturing allow for ultra low-cost solutions for at-home, point-of-care, and central laboratory testing



Intuitive and easy to use, across languages,

education levels, and disabilities



As accurate as a

laboratory PCR test:

>95% sensitivity and

100% specificity*



Results in 30 minutes or less


The National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech program awards Domus a multi-million dollar grant.

The RADx Coordination Center at CIMIT, on behalf of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the National Institutes of Health (NIH), selected Domus Diagnostics earlier this year from among hundreds of applicants to participate in their High-Performance COVID-19 Rapid Tests Fast-Track Program, to accelerate the development of their ultra-low-cost  nucleic acid at-home test.

bottom of page